{"id":23917,"date":"2024-04-22T11:27:56","date_gmt":"2024-04-22T09:27:56","guid":{"rendered":"https:\/\/ggba.swiss\/isospec-pioneers-rapid-diagnostic-technologies-with-usd-1-9-million-funding\/"},"modified":"2024-04-22T11:31:00","modified_gmt":"2024-04-22T09:31:00","slug":"le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/","title":{"rendered":"Le pionnier des technologies de diagnostic rapide, Isospec, l\u00e8ve USD 1,9 million"},"content":{"rendered":"\n

Isospec<\/a> est sp\u00e9cialis\u00e9e dans l’analyse de petites mol\u00e9cules pr\u00e9sentes dans le sang, ce qui permet d’obtenir rapidement des informations approfondies sur la sant\u00e9 humaine et d’am\u00e9liorer consid\u00e9rablement le diagnostic et le traitement des maladies. L’entreprise, qui exerce actuellement ses activit\u00e9s dans un laboratoire, a d\u00e9j\u00e0 commenc\u00e9 \u00e0 proposer commercialement des services d’identification mol\u00e9culaire \u00e0 des clients en Europe, aux \u00c9tats-Unis et au Japon. Cette aptitude est essentielle, car les m\u00e9thodes traditionnelles peuvent prendre des semaines ou des mois pour identifier une fraction des mol\u00e9cules que la technologie d’Isospec peut d\u00e9tecter en quelques heures. Ce processus d’identification rapide est le fruit de l’int\u00e9gration de domaines de pointe tels que la chimie analytique, la photonique et la cryog\u00e9nie.<\/p>\n\n\n\n

L’approche r\u00e9volutionnaire de l’entreprise vaudoise permet non seulement d’acc\u00e9l\u00e9rer le processus d’identification, mais aussi d’am\u00e9liorer la compr\u00e9hension des maladies en d\u00e9tectant dans le sang des biomarqueurs qui indiquent des probl\u00e8mes de sant\u00e9, tels que le cancer du poumon, d\u00e8s leur apparition. Cette d\u00e9tection pr\u00e9coce est essentielle pour un traitement rapide et efficace.<\/p>\n\n\n\n

En outre, les collaborations d’Isospec avec les h\u00f4pitaux et les instituts de recherche sont cruciales, car ils travaillent ensemble pour comprendre l’importance de ces biomarqueurs dans les contextes cliniques. L’objectif est de mettre au point des tests diagnostiques permettant d’\u00e9valuer rapidement et pr\u00e9cis\u00e9ment l’\u00e9tat de sant\u00e9 des patients et d’am\u00e9liorer ainsi leur \u00e9tat de sant\u00e9.<\/p>\n\n\n\n

Isospec pr\u00e9voit d’utiliser son r\u00e9cent financement pour investir dans les technologies d’automatisation et l’ing\u00e9nierie logicielle, afin d’am\u00e9liorer ses capacit\u00e9s de test et son efficacit\u00e9 op\u00e9rationnelle. Le financement de USD 1,9 million soutiendra la croissance de l’entreprise et l’aidera \u00e0 acc\u00e9l\u00e9rer la commercialisation de ses services de diagnostic.<\/p>\n\n\n\n

Le potentiel d’Isospec s’\u00e9tend au-del\u00e0 du diagnostic, car les connaissances acquises gr\u00e2ce \u00e0 sa technologie pourraient d\u00e9boucher sur la mise au point de nouveaux m\u00e9dicaments et de nouveaux traitements. L’investissement de Founderful<\/a> et d’autres partenaires t\u00e9moigne d’une grande confiance dans la technologie de diagnostic innovante d’Isospec, qui promet de transformer les diagnostics m\u00e9dicaux et les approches th\u00e9rapeutiques. Cette avanc\u00e9e pourrait am\u00e9liorer consid\u00e9rablement les soins aux patients et la qualit\u00e9 de vie dans le monde entier.<\/p>\n","protected":false},"excerpt":{"rendered":"

Isospec Analytics, une start-up vaudoise sp\u00e9cialis\u00e9e dans l’analyse biomol\u00e9culaire, a obtenu un financement de pr\u00e9-amor\u00e7age de USD 1,9 million pour faire progresser ses technologies de diagnostic r\u00e9volutionnaires.<\/p>\n","protected":false},"author":6,"featured_media":23914,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1210,1148,1141,1171],"class_list":["post-23917","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-diagnostic-fr-2","tag-financing-fr-2","tag-personalized-medicine-fr-2","tag-pharma-fr-2"],"acf":[],"yoast_head":"\nIsospec l\u00e8ve USD 1,9 million pour ses technologies de diagnostic<\/title>\n<meta name=\"description\" content=\"Isospec Analytics, une start-up sp\u00e9cialis\u00e9e dans l'analyse biomol\u00e9culaire, a obtenu un financement de pr\u00e9-amor\u00e7age de USD 1,9 million.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Isospec l\u00e8ve USD 1,9 million pour ses technologies de diagnostic\" \/>\n<meta property=\"og:description\" content=\"Isospec Analytics, une start-up sp\u00e9cialis\u00e9e dans l'analyse biomol\u00e9culaire, a obtenu un financement de pr\u00e9-amor\u00e7age de USD 1,9 million.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-22T09:27:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-22T09:31:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1179\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Le pionnier des technologies de diagnostic rapide, Isospec, l\u00e8ve USD 1,9 million\",\"datePublished\":\"2024-04-22T09:27:56+00:00\",\"dateModified\":\"2024-04-22T09:31:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/\"},\"wordCount\":428,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg\",\"keywords\":[\"Biotech\",\"Diagnostic\",\"Financing\",\"Personalized Medicine\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/\",\"name\":\"Isospec l\u00e8ve USD 1,9 million pour ses technologies de diagnostic\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg\",\"datePublished\":\"2024-04-22T09:27:56+00:00\",\"dateModified\":\"2024-04-22T09:31:00+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Isospec Analytics, une start-up sp\u00e9cialis\u00e9e dans l'analyse biomol\u00e9culaire, a obtenu un financement de pr\u00e9-amor\u00e7age de USD 1,9 million.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg\",\"width\":1179,\"height\":811,\"caption\":\"Fond\u00e9e par Thomas Rizzo, Ahmed Ben Faleh et Stephan Warnke, anciens dipl\u00f4m\u00e9s de l'EPFL, Isospec s'appr\u00eate \u00e0 transformer les diagnostics de sant\u00e9 gr\u00e2ce \u00e0 sa capacit\u00e9 unique \u00e0 identifier rapidement une vaste gamme de mol\u00e9cules \u00e0 partir d'\u00e9chantillons de sang humain. | \u00a9 Isospec\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le pionnier des technologies de diagnostic rapide, Isospec, l\u00e8ve USD 1,9 million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Isospec l\u00e8ve USD 1,9 million pour ses technologies de diagnostic","description":"Isospec Analytics, une start-up sp\u00e9cialis\u00e9e dans l'analyse biomol\u00e9culaire, a obtenu un financement de pr\u00e9-amor\u00e7age de USD 1,9 million.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/","og_locale":"fr_FR","og_type":"article","og_title":"Isospec l\u00e8ve USD 1,9 million pour ses technologies de diagnostic","og_description":"Isospec Analytics, une start-up sp\u00e9cialis\u00e9e dans l'analyse biomol\u00e9culaire, a obtenu un financement de pr\u00e9-amor\u00e7age de USD 1,9 million.","og_url":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-04-22T09:27:56+00:00","article_modified_time":"2024-04-22T09:31:00+00:00","og_image":[{"width":1179,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Le pionnier des technologies de diagnostic rapide, Isospec, l\u00e8ve USD 1,9 million","datePublished":"2024-04-22T09:27:56+00:00","dateModified":"2024-04-22T09:31:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/"},"wordCount":428,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg","keywords":["Biotech","Diagnostic","Financing","Personalized Medicine","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/","url":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/","name":"Isospec l\u00e8ve USD 1,9 million pour ses technologies de diagnostic","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg","datePublished":"2024-04-22T09:27:56+00:00","dateModified":"2024-04-22T09:31:00+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Isospec Analytics, une start-up sp\u00e9cialis\u00e9e dans l'analyse biomol\u00e9culaire, a obtenu un financement de pr\u00e9-amor\u00e7age de USD 1,9 million.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/04\/Isospec-1180x811-1.jpg","width":1179,"height":811,"caption":"Fond\u00e9e par Thomas Rizzo, Ahmed Ben Faleh et Stephan Warnke, anciens dipl\u00f4m\u00e9s de l'EPFL, Isospec s'appr\u00eate \u00e0 transformer les diagnostics de sant\u00e9 gr\u00e2ce \u00e0 sa capacit\u00e9 unique \u00e0 identifier rapidement une vaste gamme de mol\u00e9cules \u00e0 partir d'\u00e9chantillons de sang humain. | \u00a9 Isospec"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/le-pionnier-des-technologies-de-diagnostic-rapide-isospec-leve-usd-19-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Le pionnier des technologies de diagnostic rapide, Isospec, l\u00e8ve USD 1,9 million"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=23917"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23917\/revisions"}],"predecessor-version":[{"id":23919,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23917\/revisions\/23919"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/23914"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=23917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=23917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=23917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}